Novoron Bioscience
Novoron Bioscience develops new therapeutic approaches to address neurological damage or disease in the central nervous system (CNS). Our novel LRP-focused science enables hope for treatment of conditions for which no current therapies exist. We’re advancing multiple biological therapeutics that treat pathologies of the CNS, including tauopathies (Alzheimer’s, CTE, TBI, etc.), acute spinal cord injury (orphan drug indication), and demyelinating conditions (multiple sclerosis, NMO, etc.).
Tech Stack (10 technologies)
Frequently Asked Questions
What technologies does Novoron Bioscience use?+
Novoron Bioscience uses 10 technologies including Adobe Fonts, Squarespace, Squarespace Commerce.
What industry is Novoron Bioscience in?+
Novoron Bioscience operates in the Biopharma industry.
Where is Novoron Bioscience based?+
Novoron Bioscience is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026